World / Immunology
06.11.2009 08:14
medicalnewstoday.com
An experimental vaccine to treat precancerous vulvar growths eliminated the growths in nine of 20 women participating in a small trial, according to a study published in the New England Journal of Medicine, Reuters reports.
World
Immunology
A key player in a cascade that likely begins with stress and leads to high blood pressure and kidney...
U.S. health officials briefing Congress on Wednesday would not outline a timeline for when enough H1...
The Wall Street Journal examines "big pharma's growing interest in a corner of healthcare - emer...
Raynaud's is a common condition, especially in teenagers, affecting approximately 10 million people ...
Antigenics, Inc. (NASDAQ: AGEN) today indicated that GlaxoSmithKline's (GSK) Phase III malaria vacci...
Subsidized artemisinin-based combination therapies (ACTs) under the Affordable Medicines Facilit...
A WHO official on Tuesday backed the Afghan government's decision to declare H1N1 (swine flu) a heal...
To mark the first World Pneumonia Day, Inter Press Service examines how vaccines and other strategie...
Researchers have new evidence to explain how saturated fatty acids, which soar in those who are obes...
On Tuesday at the 5th Multilateral Initiative on Malaria (MIM) Pan-African Conference in Nairobi...
Date: 30 July 2010 - 00:44
Number of sources in English: 130